Clinical Trials on Opioid Abuse (Disorder)

Total 144921 results

Elias Dakwar

Recruiting

Breathwork-assisted Treatment for Cannabis Use Disorder

Addiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use Disorder

United States
Parnassia Addiction Research Centre
Radboud University Medical Center; Columbia University; Academisch Medisch Centrum... and other collaborators

Not yet recruiting

Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

Cocaine Use Disorder
Boston VA Research Institute, Inc.
Patient-Centered Outcomes Research Institute; Boston University; International...

Recruiting

COVID-19-Related Opioid Treatment Policy Evaluation (COPE)

Alcohol Use Disorder | Opioid-use Disorder

United States
Indiana University School of Medicine
Walther Cancer Institute

Completed

A Feasibility Study of Smoking Cessation Program in Radiation Oncology

Cancer and Tobacco Abuse

United States
University of Connecticut
National Institute on Drug Abuse (NIDA)

Completed

Testing of the Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs Program (iRaPID)

Opioid-use Disorder | HIV Prevention Program

United States
University of Colorado, Denver

Active, not recruiting

Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain

Chronic Pain | Opioid-use Disorder

United States
VA Office of Research and Development

Completed

Stimulant Oxytocin Study (SOS)

Stimulant Use & Co-occuring Opioid Use Disorders

United States
Laureate Institute for Brain Research, Inc.
Oklahoma Center for the Advancement of Science and Technology

Completed

Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder (NEAT)

Opioid-use Disorder | Amphetamine Use Disorders

United States
Emory University
National Institute on Drug Abuse (NIDA)

Recruiting

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 (VNS in OUD UH3)

Opioid Use Disorder | Opioid Use | Withdrawal Symptoms

United States
Milton S. Hershey Medical Center

Not yet recruiting

fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD

Alcoholism | Alcohol Use Disorder | Opioid-use Disorder | Neurofeedback | Prescription Drug Dependence
University of Pennsylvania

Completed

Increasing Implementation of Post-Operative Opioid Prescribing Guidelines

Surgery | Opioid Use | Opioid Misuse | Prescription Opioid Misuse

United States
Washington State University

Not yet recruiting

Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment (MIRROM)

Stimulant Use Disorder
William Stoops
National Institute on Drug Abuse (NIDA)

Recruiting

Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine) (BED IN 43)

Opioid Use Disorder | Cocaine Use Disorder

United States
Johns Hopkins University

Recruiting

Suvorexant for Opioid/Stimulant Co-use

Opioid Use Disorder | Stimulant Use Disorder

United States
University of Minnesota

Active, not recruiting

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

Opioid Use Disorder | Stimulant Use Disorder

United States
West Chester University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Recruiting

Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder

Opioid-use Disorder

United States
University of California, Davis
Yale University; University of Utah

Not yet recruiting

Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder (PEDsTREATOUD)

Opioid-use Disorder
Yale University
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Emergency Department-Initiated Buprenorphine Validation Network Trial

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Emergency Department Outcomes for Patients With Opioid Use Disorder

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder (ED-CONNECT)

Opioid-use Disorder

United States
Universita degli Studi di Catania
Laboratory for Health Protection Research

Completed

Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes (KINECIG)

Tobacco Abuse Smoke

Italy
Treatment Research Institute

Completed

CRAFT Behavior Therapy: Treatment Entry Component

Alcohol Dependence | Substance Abuse | Drug Addiction | Opiate Dependence | Stimulant Dependence

United States
University of Maryland, Baltimore

Terminated

Ketamine for OUD and Comorbid Depression (OUDCD)

Depressive Disorder | Opioid Use Disorder

United States
University of Zurich

Completed

Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients (RELZH12)

Opioid Use, Unspecified With Other Opioid-induced Disorder

Switzerland
Johns Hopkins University

Completed

Recovery Housing and Drug Abuse Treatment Outcome

Opiate Addiction | Mental and Behavioral Disorders Due to Use of Cocaine: Harmful Use

United States
VA Office of Research and Development
US Department of Veterans Affairs

Completed

Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking (MISSION-HPACT)

Mental Illness | Co-Occurring Disorders | Homelessness | Substance Abuse Disorder

United States
Butler Hospital
National Institute on Drug Abuse (NIDA)

Recruiting

tDCS to Decrease Opioid Relapse (UH3)

Opioid Use Disorder

United States
Prisma Health-Upstate
National Institute on Drug Abuse (NIDA); Clemson University

Recruiting

Development, Refinement, and Validation of a Peer Support Specialist Checklist for Individuals With Opioid Use Disorder / STAMPS: South Carolina Buprenorphine Treatment Initiation, Adherence, and Retention Utilizing Mobile Health Units and Peer Support Specialists

Opioid Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
Friends Research Institute, Inc.

Not yet recruiting

Buprenorphine for Individuals in Jail

Opioid Use Disorder

United States
University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Recruiting

A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Assessing Optimal XRB Initiation Points in Jail

Opioid Use Disorder

United States
University Hospital, Strasbourg, France

Recruiting

Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach (BEBOP)

Opioid Use Disorder

France
Philadelphia College of Osteopathic Medicine
Prevention Point Philadelphia

Recruiting

Cognitive-Behavioral Therapy for Opioid Use Disorder: A Manualized Pilot Study

Opioid Use Disorder

United States
Friends Research Institute, Inc.
MATClinics

Recruiting

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Opioid Use Disorder

United States
Pouya Azar

Recruiting

Symptom-inhibited Fentanyl Induction (SIFI)

Opioid Use Disorder

Canada
University of Kentucky
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Cannabis and Opioid Use Disorder

Opioid Use Disorder
Gazi University

Recruiting

Investigation of the Relationship Between Different Assesments in Individuals in Opioid Maintenance Treatment Process

Opioid Use Disorder

Turkey
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); Aptinyx

Recruiting

Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

Opioid Use Disorder

United States
VA Office of Research and Development

Recruiting

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder (VA-BRAVE)

Opioid Use Disorder

United States
Center for Social Innovation, Massachusetts
West Haven VA

Completed

Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment (OASIS)

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
3D Therapy, LLC

Completed

The Feasibility of VR for OUD

Opioid Use Disorder

United States
Johns Hopkins University

Withdrawn

Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

Opioid Use Disorder
Masimo Corporation

Enrolling by invitation

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Opioid Use Disorder

United States
AstraZeneca

Completed

A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.

Opioid Use Disorder

United States
Carilion Clinic

Completed

START NOW in the Treatment of Opioid Addicted Individuals

Opioid Use Disorder

United States
Mclean Hospital
National Institute on Drug Abuse (NIDA)

Terminated

A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders

Opioid Use Disorder

United States

Clinical Trials on Opioid Abuse (Disorder)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations